TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 40 filers reported holding TAYSHA GENE THERAPIES INC in Q2 2023. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 16,140 | $10,669 | 0.00% |
| MORGAN STANLEY | 131,308 | $86,794 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 70,798 | $46 | 0.00% |
| BlackRock Inc. | 321,025 | $212,197 | 0.00% |
| Citadel Advisors | 1,500 | $992 | 0.00% |
| Citadel Advisors | 1,100 | $727 | 0.00% |
| Citadel Advisors | 11,293 | $7,465 | 0.00% |
| SIMPLEX TRADING, LLC | 5,881 | $3 | 0.00% |
| NORTHERN TRUST CORP | 72,958 | $48,225 | 0.00% |
| JPMORGAN CHASE & CO | 1,782 | $1,178 | 0.00% |
| Renaissance Technologies | 224,400 | $148 | 0.00% |
| COMMONWEALTH EQUITY SERVICES, LLC | 18,725 | $12 | 0.00% |
| ROYAL BANK OF CANADA | 150 | $0 | 0.00% |
| Allworth Financial LP | 1,000 | $661 | 0.00% |
| VANGUARD GROUP INC | 1,589,248 | $1,050,493 | 0.00% |
| UBS Group AG | 7,909 | $5,228 | 0.00% |
| Engineers Gate Manager LP | 13,650 | $9,023 | 0.00% |
| Squarepoint Ops LLC | 80,634 | $53,299 | 0.00% |
| Kovitz Investment Group Partners, LLC | 15,000 | $9,915 | 0.00% |
| FMR LLC | 1,148,827 | $759,374 | 0.00% |
External links
This page lists TAYSHA GENE THERAPIES INC's shareholders in Q2 2023. To view TAYSHA GENE THERAPIES INC's shareholder history, click here.